Hypoglycemic Agents: all 3,927 studies that test it

Page 21 of 40. Open to participants first (294), then studies with results posted, then the rest; newest registration first within each.

• Cancer Chemoprevention by Metformin Hydrochloride in Oral Potentially Malignant LesionsStatus unknownNCT03685409Phase 3
• Cancer Chemoprevention by Metformin Hydrochloride Compared to Placebo in Oral Potentially Malignant LesionsStatus unknownNCT03684707Phase 4
• Azithromycin Insulin Diet Intervention Trial in Type 1 DiabetesStatus unknownNCT03682640Phase 2
• Metformin Use and Clinical Pregnancy Rate in Women With Unexplained InfertilityStatus unknownNCT03681197Early Phase 1
• Effect of Evogliptin on Albuminuria in Patients With Type 2 Diabetes and Renal InsufficiencyCompletedNCT03667300Phase 2
• Diluted Insulin in Young Children: Bigger Volumes for Smaller PatientsCompletedNCT03666065Early Phase 1
• Insulin Treatment in Diabetic Older People With Heart Failure.TerminatedNCT03665350Phase 2
• Tight Versus Liberal Blood Glucose Control in Adult Critically Ill PatientsActive, not recruitingNCT03665207Phase 3
• Comparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 DiabetesCompletedNCT03659799Phase 4
• Glucagon-like Peptide-1 Levels, Insulin Resistance and Insulin Sensitivity Index in Type 2 Diabetes MellitusCompletedNCT03659461Not applicable
• Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 DiabetesCompletedNCT03655535Phase 2
• Pupillography as Screening Tool for Brain Insulin ResistanceCompletedNCT03651661Not applicable
• Comparison of Insulin Alone to Insulin With Metformin to Treat Gestational Diabetes MellitusTerminatedNCT03651531Phase 3
• Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D484 in Healthy AdultsStatus unknownNCT03646799Phase 1
• Antidiabetic Drugs for Steatotic Liver DiseaseCompletedNCT03646292Phase 4
• Efficacy and Safety of Empagliflozin in NODATTerminatedNCT03642184Phase 4
• The Effects of Empagliflozin on Arterial Wall CharacteristicsStatus unknownNCT03639545Phase 4
• Effect of Intranasal Insulin on Cognitive Processes and AppetiteCompletedNCT03632681Not applicable
• Metformin for Treatment of Psoriasis Combined With Disorders of Glucose and Lipid MetabolismStatus unknownNCT03629639Phase 4
• Metformin for Pulmonary Hypertension HFpEFCompletedNCT03629340Phase 2
• Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell CarcinomaCompletedNCT03618654Early Phase 1
• Comparison of the Effectiveness Metformin for Deceasing Proliferative Marker in Endometrial Cancer CellsCompletedNCT03618472Not applicable
• Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes MellitusActive, not recruitingNCT03606694Phase 2
• A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Lispro to Humalog® in Healthy SubjectsCompletedNCT03604575Not applicable
• Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF)Active, not recruitingNCT03603912Phase 4
• Effects of a Dipeptidyl Peptidase-4 Inhibitor Sitagliptininsulin on the Progression of Coronary Atherosclerosis in Patients With Type 2 DiabetesStatus unknownNCT03602638Phase 4
• A Clinical Trial of Metformin in the Maintenance of Non-Hodgkin's Lymphoma PatientsStatus unknownNCT03600363Phase 2
• Effect and Safety of Benaglutide or Metformin in Patients With Simple Obesity Who Have Inadequate Weight ControlStatus unknownNCT03593668Phase 4
• Effect of Metformin as add-on Therapy on Glycemic Control and Other Outcomes in Type 1 DiabetesStatus unknownNCT03590262Phase 4
• Metformin for Preeclampsia Prevention in Pregnant Women With Type 1 Diabetes MellitusCompletedNCT03570632Phase 4
• Glibenclamide in Aneurysmatic Subarachnoid HemorrhageStatus unknownNCT03569540Phase 4
• Pioglitazone Versus Metformin as First Treatment in Infertile Women With Polycystic Ovary SyndromeCompletedNCT03566225Early Phase 1
• Multi-Center Development of a Novel Diagnostic Test for Alzheimer's DiseaseActive, not recruitingNCT03560960Early Phase 1
• Effect of Fertility-sparing Therapy of Early Endometrial CancerStatus unknownNCT03538704Not applicable
• Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)CompletedNCT03529123Phase 3
• Gestational Diabetes and Pharmacotherapy (GAP)Active, not recruitingNCT03527537Phase 4
• A Clinical Trial of Metformin to Decrease Glucocorticoids Side Effects in Patients With Autoimmune UveitisStatus unknownNCT03525028Not applicable
• DANHEART (H-HeFT and Met-HeFT)CompletedNCT03514108Phase 4
• Metformin Plus Insulin on Non-obese Autoimmune DiabetesStatus unknownNCT03513874Phase 4
• Metformin in Head and Neck Squamous Cell Carcinoma: Effect on Tissue OxygenationCompletedNCT03510390Not applicable
• Intensive Versus Conventional Hyperglycemic Control in Hospitalized Non-critically Ill PatientsCompletedNCT03510078Not applicable
• Effectiveness of Glucose Control, β Cell Function in Response to Short-term Insulin Pump Therapy in Type 2 DiabetesCompletedNCT03509324Phase 4
• Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)WithdrawnNCT03504566Phase 4
• The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) ProgramCompletedNCT03503942Not applicable
• Intensive Insulin for Severe/Moderate Hypertriglyceridemia Pancreatitis.Status unknownNCT03501680Phase 4
• Vildagliptin on Gastric AccommodationCompletedNCT03500900Not applicable
• A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin TherapyCompletedNCT03499704Phase 4
• Treatment of Bardet-Biedl-Syndrome With Metformin for Evaluation of a Possible Visual ImprovementWithdrawnNCT03490019Phase 2
• Androgen Responses to hCG and Ovarian Morphology in PCOSStatus unknownNCT03489668Not applicable
• Endometrial Thickness and Subendometrial Vascularity in Anovulatory Polycystic Ovarian Syndrome Patients Treated by MetforminStatus unknownNCT03486626Phase 4
• A Trial of Metformin in Individuals With Fragile X SyndromeCompletedNCT03479476Phase 2/3
• Defining the Clinical Role of Topiramate in the Treatment of Alcohol Dependence in AustraliaStatus unknownNCT03479086Phase 3
• USE THE SYSTEMIC METFORMIN IN MELASMAStatus unknownNCT03475524Phase 4
• Study of Metformin Plus Oligomeric Procyanidin Complex for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer PatientsWithdrawnNCT03465345Phase 1
• Bioequivalence Study of Metformin 1000 mg Tablets Immediate Release (IR) Versus Glucophage® 1000 mg Tablets IR In Healthy SubjectsCompletedNCT03458208Phase 1
• Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450sCompletedNCT03457597Phase 1
• Bioequivalence Study of Metformin 750 mg Tablets XR Versus Glucophage® Long 750 mg Tablets XR In Normal Healthy Subjects Under Fasting and Fed ConditionsCompletedNCT03452306Phase 1
• Insulin Signaling in Skeletal MuscleWithdrawnNCT03452267Phase 2/3
• Metformin Gastrointestinal Intolerance: Measurement of Mitochondrial Complex ICompletedNCT03445702Early Phase 1
• Efficacy of Metformin in Preventing Diabetes in ChinaCompletedNCT03441750Phase 4
• Study of Pioglitazone in Sporadic Inclusion Body MyositisCompletedNCT03440034Phase 1
• Safety Assessment of SAR341402 and NovoLog® Used in Continuous Subcutaneous Insulin Infusion for Type 1 Diabetes Mellitus PatientsCompletedNCT03436498Phase 1
• Renal Actions of Combined Empagliflozin and LINagliptin in Type 2 diabetESStatus unknownNCT03433248Phase 4
• Absolute Bioavailability Study With BexagliflozinWithdrawnNCT03417076Phase 1
• A Trial Comparing the Pharmacokinetic Properties of Fast-acting Insulin Aspart Between Children, Adolescents and Adults With Type 1 DiabetesCompletedNCT03407599Phase 1
• Phase 4 Study to Evaluate Treatment Optimization With Once-daily Insulin Glargine 300 U/mLCompletedNCT03406000Phase 4
• Regulation of Endogenous Glucose Production by Brain Insulin Action in Insulin ResistanceCompletedNCT03383822Phase 1/2
• IMPACT: A Randomized WOO Study of Novel Therapeutic Agents in Women Triaged to Primary Surgery for EOCCompletedNCT03378297Early Phase 1
• Determination of the PPG and Insulin Responses of Rice Alone and Rice Consumed With Sugardown™CompletedNCT03375398Not applicable
• Determination of the GI and II Values of Soft Drink and Soft Drink With Sugardown™CompletedNCT03374501Not applicable
• Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT AloneStatus unknownNCT03370705Phase 3
• A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)CompletedNCT03367390Phase 1
• GPPAD-POInT (Global Platform of Autoimmune Diabetes - Primary Oral Insulin Trial)CompletedNCT03364868Phase 2
• A Study to Evaluate the Effect of Multiple Doses of CC-90001 on the Pharmacokinetics of Omeprazole, Midazolam, Warfarin, Rosuvastatin, Metformin, Digoxin, and Nintedanib in Healthy Adult SubjectsCompletedNCT03363815Phase 1
• Pharmacokinetics of Metformin IntoleranceCompletedNCT03361878Phase 4
• Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin TherapyCompletedNCT03359837Phase 4
• Metformin Treatment for Colon CancerCompletedNCT03359681Phase 2
• Research of Exenatide for Overweight/Obese PCOS Patients With IGRCompletedNCT03352869Phase 4
• Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in RamadanTerminatedNCT03349840Phase 4
• Intravenous Administration of Insulin and Plasma Exchange on Triglyceride Levels in Early Stage of Hypertriglyceridemia-induced PancreatitisStatus unknownNCT03342807Phase 4
• Effect of Metformin and Probiotics in Reproductive-aged Patients With Polycystic Ovary SyndromeStatus unknownNCT03336840Not applicable
• CORT125281 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)CompletedNCT03335956Phase 1
• Inter- and Intra-individual Variations in Metformin Pharmacokinetics - The Importance of Genes and Drug InteractionsCompletedNCT03335423Phase 1
• The Interaction Between Metformin and Acute ExerciseCompletedNCT03329651Not applicable
• Impact on the Oxidative Stress of the Different Analogues of Insulin in People With Type 1 Diabetes. (Ineox Study)CompletedNCT03328845Phase 4
• The Effect of Intranasal Insulin Administration on Cognitive Function After Cardiac Surgery.Status unknownNCT03324867Not applicable
• Comparison of Metformin and Insulin for Management of Gestational Diabetes MellitusCompletedNCT03320694Phase 3
• A Study of Adding Linagliptin to Control Glycemic Variability and HbA1c in Peritoneal Dialysis Patients With Type 2 Diabetes(PDPD) With Premixed Insulin TherapyStatus unknownNCT03320031Phase 4
• The Interaction Between Metformin and Physical TrainingCompletedNCT03316690Not applicable
• A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced MelanomaActive, not recruitingNCT03311308Phase 1
• An Assessment of Pharmacokinetic Gemigliptin and Metformin Interactions in Healthy Mexican VolunteersCompletedNCT03310749Phase 1
• A Pilot Study of Rosiglitazone in the Treatment of GH Secreting Pituitary AdenomasStatus unknownNCT03309319Not applicable
• PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPDTerminatedNCT03307512Phase 2
• Safety and Efficacy of Glibenclamide Combined With Rt-PA in Acute Cerebral EmbolismCompletedNCT03284463Phase 2/3
• Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With MigraineWithdrawnNCT03280342Phase 2
• Metformin Treatment on Cognitive Impairment of Schizophrenia Co-morbid Metabolic SyndromeStatus unknownNCT03271866Not applicable
• A Study to Assess the Effect of Plazomicin on the Pharmacokinetics of MetforminCompletedNCT03270553Phase 1
• Metformin Treatment of Pregnant Women With Polycystic Ovary Syndrome: a Pilot StudyCompletedNCT03259919Phase 2
• Metformin Versus Vildagliptin for Diabetic Hypertensive PatientsCompletedNCT03253562Phase 4
• The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin in Patients With T2DCompletedNCT03246451Not applicable

← Hypoglycemic Agents overview